Purinergic Receptor Expression and Activation in First Trimester and Term Human Placenta

Victoria Roberts, L. H. Waters, T. Powell

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Intracellular calcium concentration ([Ca2+]i) is an important signalling molecule in the human placenta and regulation of [Ca2+]i must be tightly controlled to ensure normal cell function and in order to meet the changing demand for calcium with increased fetal growth over gestation. Little is known about the receptors and mechanisms involved in intracellular calcium signalling in the human placenta but in isolated cytotrophoblast cells members of the P2 purinergic receptor family have been shown to mediate an ATP-stimulated rise in [Ca2+]i. In this study we examined activation and expression of several of the purinergic receptor subtypes in human placental villous fragments at two stages of gestation, first trimester and term. We demonstrate mRNA and protein expression of the P2X4, P2X7 and P2Y2 subtypes but found no evidence of P2Y4 protein in the placenta. Using fluorescent calcium imaging we demonstrate that 300 μM ATP, 450 μM UTP and 300 μM BzATP significantly elevate [Ca2+]i in villous fragments with a significant increase in agonist-induced response seen in the term compared to the first trimester fragments (ATP, P <0.0001; UTP, P = 0.018; BzATP, P = 0.015). The roles of the purinergic receptors within the human placenta are not known but it seems likely for this study that calcium handling through these receptors is altered with advancing gestation. This may be due to the need to meet increased fetal Ca2+ requirements due to growth or as a secondary function to alterations in placental [Ca2+]i signalling.

Original languageEnglish (US)
Pages (from-to)339-347
Number of pages9
JournalPlacenta
Volume28
Issue number4
DOIs
StatePublished - Apr 2007
Externally publishedYes

Fingerprint

Purinergic Receptors
First Pregnancy Trimester
Placenta
Calcium
Uridine Triphosphate
Adenosine Triphosphate
Pregnancy
Purinergic P2 Receptors
Calcium Signaling
Trophoblasts
Fetal Development
Proteins
Messenger RNA
Growth
3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate

Keywords

  • Calcium
  • Placenta
  • Purinergic receptor

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Purinergic Receptor Expression and Activation in First Trimester and Term Human Placenta. / Roberts, Victoria; Waters, L. H.; Powell, T.

In: Placenta, Vol. 28, No. 4, 04.2007, p. 339-347.

Research output: Contribution to journalArticle

Roberts, Victoria ; Waters, L. H. ; Powell, T. / Purinergic Receptor Expression and Activation in First Trimester and Term Human Placenta. In: Placenta. 2007 ; Vol. 28, No. 4. pp. 339-347.
@article{39a95131955b4914a356bdd65779b8e8,
title = "Purinergic Receptor Expression and Activation in First Trimester and Term Human Placenta",
abstract = "Intracellular calcium concentration ([Ca2+]i) is an important signalling molecule in the human placenta and regulation of [Ca2+]i must be tightly controlled to ensure normal cell function and in order to meet the changing demand for calcium with increased fetal growth over gestation. Little is known about the receptors and mechanisms involved in intracellular calcium signalling in the human placenta but in isolated cytotrophoblast cells members of the P2 purinergic receptor family have been shown to mediate an ATP-stimulated rise in [Ca2+]i. In this study we examined activation and expression of several of the purinergic receptor subtypes in human placental villous fragments at two stages of gestation, first trimester and term. We demonstrate mRNA and protein expression of the P2X4, P2X7 and P2Y2 subtypes but found no evidence of P2Y4 protein in the placenta. Using fluorescent calcium imaging we demonstrate that 300 μM ATP, 450 μM UTP and 300 μM BzATP significantly elevate [Ca2+]i in villous fragments with a significant increase in agonist-induced response seen in the term compared to the first trimester fragments (ATP, P <0.0001; UTP, P = 0.018; BzATP, P = 0.015). The roles of the purinergic receptors within the human placenta are not known but it seems likely for this study that calcium handling through these receptors is altered with advancing gestation. This may be due to the need to meet increased fetal Ca2+ requirements due to growth or as a secondary function to alterations in placental [Ca2+]i signalling.",
keywords = "Calcium, Placenta, Purinergic receptor",
author = "Victoria Roberts and Waters, {L. H.} and T. Powell",
year = "2007",
month = "4",
doi = "10.1016/j.placenta.2006.04.007",
language = "English (US)",
volume = "28",
pages = "339--347",
journal = "Placenta",
issn = "0143-4004",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Purinergic Receptor Expression and Activation in First Trimester and Term Human Placenta

AU - Roberts, Victoria

AU - Waters, L. H.

AU - Powell, T.

PY - 2007/4

Y1 - 2007/4

N2 - Intracellular calcium concentration ([Ca2+]i) is an important signalling molecule in the human placenta and regulation of [Ca2+]i must be tightly controlled to ensure normal cell function and in order to meet the changing demand for calcium with increased fetal growth over gestation. Little is known about the receptors and mechanisms involved in intracellular calcium signalling in the human placenta but in isolated cytotrophoblast cells members of the P2 purinergic receptor family have been shown to mediate an ATP-stimulated rise in [Ca2+]i. In this study we examined activation and expression of several of the purinergic receptor subtypes in human placental villous fragments at two stages of gestation, first trimester and term. We demonstrate mRNA and protein expression of the P2X4, P2X7 and P2Y2 subtypes but found no evidence of P2Y4 protein in the placenta. Using fluorescent calcium imaging we demonstrate that 300 μM ATP, 450 μM UTP and 300 μM BzATP significantly elevate [Ca2+]i in villous fragments with a significant increase in agonist-induced response seen in the term compared to the first trimester fragments (ATP, P <0.0001; UTP, P = 0.018; BzATP, P = 0.015). The roles of the purinergic receptors within the human placenta are not known but it seems likely for this study that calcium handling through these receptors is altered with advancing gestation. This may be due to the need to meet increased fetal Ca2+ requirements due to growth or as a secondary function to alterations in placental [Ca2+]i signalling.

AB - Intracellular calcium concentration ([Ca2+]i) is an important signalling molecule in the human placenta and regulation of [Ca2+]i must be tightly controlled to ensure normal cell function and in order to meet the changing demand for calcium with increased fetal growth over gestation. Little is known about the receptors and mechanisms involved in intracellular calcium signalling in the human placenta but in isolated cytotrophoblast cells members of the P2 purinergic receptor family have been shown to mediate an ATP-stimulated rise in [Ca2+]i. In this study we examined activation and expression of several of the purinergic receptor subtypes in human placental villous fragments at two stages of gestation, first trimester and term. We demonstrate mRNA and protein expression of the P2X4, P2X7 and P2Y2 subtypes but found no evidence of P2Y4 protein in the placenta. Using fluorescent calcium imaging we demonstrate that 300 μM ATP, 450 μM UTP and 300 μM BzATP significantly elevate [Ca2+]i in villous fragments with a significant increase in agonist-induced response seen in the term compared to the first trimester fragments (ATP, P <0.0001; UTP, P = 0.018; BzATP, P = 0.015). The roles of the purinergic receptors within the human placenta are not known but it seems likely for this study that calcium handling through these receptors is altered with advancing gestation. This may be due to the need to meet increased fetal Ca2+ requirements due to growth or as a secondary function to alterations in placental [Ca2+]i signalling.

KW - Calcium

KW - Placenta

KW - Purinergic receptor

UR - http://www.scopus.com/inward/record.url?scp=33947727616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947727616&partnerID=8YFLogxK

U2 - 10.1016/j.placenta.2006.04.007

DO - 10.1016/j.placenta.2006.04.007

M3 - Article

VL - 28

SP - 339

EP - 347

JO - Placenta

JF - Placenta

SN - 0143-4004

IS - 4

ER -